GHASSAN ALDURRA: Open Payments
NPI 1699781310 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 66 payments from 11 companies in 2025. Trend: 2023 $10,545 · 2024 $1,156 · 2025 $1,764
Food & beverage: $1,665Education: $100
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $379 |
| Teva Pharmaceuticals USA, Inc. | 10 | $319 |
| Lundbeck LLC | 11 | $296 |
| Alkermes, Inc. | 11 | $225 |
| E.R. Squibb & Sons, L.L.C. | 4 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Celgene Corporation | 1 | $74 |
| Bausch Health US, LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
Products named: REXULTI, UZEDY, ABILIFY ASIMTUFII, COBENFY, LYBALVI, TRINTELLIX, ARISTADA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
